重大公告
Supplemental Information: OBI-822 was approved to enter a Phase III clinical trial by the China Food and Drug Administration (CFDA)
Date of occurrence of the event: January 26, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …
OBI-822 was approved to enter a Phase III clinical trial by the China Food and Drug Administration (CFDA)
Date of occurrence of the event: January 25, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …
OBI Pharma Inc. announces the change of Chief Operating Officer
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or internal audit …
Clarification on the news article by Commercial Times
Date of occurrence of the event: January 21, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …
Clarification on the news article by United Daily News E-Paper
Date of occurrence of the event: January 11, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …